Your chances of receiving a liver transplant depend on a tangle of factors, and the honest answer is that they vary enormously from person to person. Nationally, the majority of people listed for a liver transplant do eventually receive one, but the path from listing to surgery can be fast or agonizingly slow depending on how sick you are, what caused your liver disease, where you live, and even your blood type. In some parts of the United States, a patient with a given severity score has an 86% chance of being transplanted within 90 days; in other parts, that figure drops to 18%.
How the Waiting List Actually Works
Liver allocation in the U.S. is managed by the United Network for Organ Sharing (UNOS) and driven primarily by a severity score called the Model for End-Stage Liver Disease, or MELD. The score runs from 6 to 40 and is calculated from a few lab values that reflect how well your liver and kidneys are functioning. A higher score means you are sicker, and sicker patients get priority. The system is designed so that the person most likely to die without a transplant gets the next available organ, not the person who has been waiting the longest.
That priority-by-sickness design has a counterintuitive consequence: patients who are very ill at the time of listing tend to get transplanted quickly, while patients who are sick enough to need a transplant but stable enough to wait can spend months or years on the list. An early analysis of a single large center found that among patients who received a first transplant, about two-thirds were transplanted within a month of being listed. But the flip side was grim: among those who died before getting a graft, nearly 80% died within that same first month, usually because their disease was so advanced that no organ arrived in time.1PubMed Central. The liver transplant waiting list–a single-center analysis The system has evolved since then, but the basic tension remains: urgency gets you to the front of the line, yet extreme urgency can also mean you run out of time.
For patients with liver cancer (hepatocellular carcinoma, or HCC), the scoring system works a bit differently. Because cancer patients can have relatively preserved liver function yet face a growing tumor, they receive standardized exception points that boost their MELD score over time. Policy changes have introduced a six-month delay before those exception points kick in, which was designed to reduce the advantage HCC patients had over non-cancer patients on the list. Modeling of that policy projected that HCC patients would still reach a transplant probability of roughly 84% by three years under the delay system, compared with lower rates under alternative scoring methods.2PubMed. Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates
Where You Live Changes Your Odds
Geography is one of the biggest and most frustrating variables in liver transplantation. The country is divided into donation service areas, and the supply of donor organs relative to the number of people waiting differs dramatically from one area to the next. Research has documented that for patients with comparable disease severity, 90-day transplant rates ranged from 18% to 86% and death rates ranged from 14% to 82% across different service areas.3American Journal of Transplantation. Addressing Geographic Disparities in Liver Transplantation Through Redistricting That is not a subtle gap. Two patients with identical lab values and identical diagnoses can face wildly different outcomes depending on which transplant center they are listed at.
Policy efforts have tried to narrow these gaps. The “Share 35” rule, introduced in 2013, required that livers be shared regionally for candidates with a MELD of 35 or higher before being offered locally to lower-scoring patients. A study examining transplant rates before and after Share 35 found that the overall geographic disparity barely budged: two candidates with the same MELD in two different service areas were still expected to have about a 2.2-fold difference in their transplant rate driven by geography alone. For patients in the MELD 15–34 range, the disparity did shrink modestly, but for the sickest patients with scores of 35–40, the geographic gap actually widened slightly.4PubMed Central. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35 Subsequent policy revisions, including the 2020 shift to broader sharing circles (called “acuity circles”), have continued trying to equalize access, though researchers note that closing the gap will take action at the patient, center, and national levels simultaneously.5PubMed Central. Geographic disparities in access to liver transplantation
Micro-geography matters too. Living farther from a transplant center increases your risk of dying on the waiting list, and neighborhood-level socioeconomic disadvantage has been linked to worse waitlist outcomes.6American Journal of Transplantation. Micro-geographic disparities in mortality and access to liver transplantation in the United States If you live in a rural area hours from the nearest transplant program, even getting evaluated and listed can be a barrier, let alone responding quickly when an organ becomes available.
What Your Diagnosis Means for Your Place in Line
Not all liver diseases carry the same transplant probability. A large U.S. study found that the likelihood of receiving a transplant has shifted over time depending on your underlying condition. After adjusting for age, sex, severity, and other factors, patients listed in more recent eras were generally less likely to be transplanted than those listed in earlier eras, and the reduction was steepest for patients with liver cancer, whether or not they also had hepatitis C.7Clinical Gastroenterology and Hepatology. Trends in Origin, Waitlist Outcome, and Posttransplant Outcomes in Liver Transplantation in the United States This partly reflects more patients being listed and more competition for available organs.
Alcohol-related liver disease deserves its own mention because for decades it carried a unique stigma in transplant medicine. Many programs required six months of sobriety before listing. That rule has loosened in recent years, particularly for patients with severe acute alcoholic hepatitis who are not responding to medical treatment. A survey of U.S. transplant programs found that about half had performed at least one transplant for that indication, though most of those had done five or fewer. The data showed that careful selection led to strong one-year survival after transplant.8PubMed. Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis The shift is real but uneven: some centers are far more willing to list these patients than others, which means your chances can depend on your transplant team’s philosophy.
What Can Get You Removed from the List
Being listed is not a guarantee you stay listed. Patients are delisted for several reasons, and understanding them helps set realistic expectations. Common reasons include the liver disease improving enough that transplant is no longer needed (which sounds like good news and often is), but also the patient’s condition deteriorating so severely that surgery would be futile. Tumor progression beyond transplant criteria, uncontrolled infections requiring ICU care, and persistent adherence problems such as continued substance use or missing critical appointments can also lead to removal.9PubMed Central. Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates Some patients are delisted temporarily and relisted once their situation stabilizes, but others are removed permanently.
Risk Factors for Dying While Waiting
Waitlist mortality has been a persistent problem. Annual mortality on the waiting list has been documented at around 10% for adults and somewhat lower for children.10PubMed. Risk factors for liver transplantation waiting list mortality The risk is not evenly distributed. Factors associated with a higher chance of dying on the list include female sex, blood type O (because compatible donors are in high demand), fulminant liver failure, higher MELD scores at time of listing, and more urgent clinical status.
Clinical complications at the time of listing also predict trouble. A single-center analysis identified ICU treatment, prior abdominal surgery, variceal bleeding, ascites, and fluid overload as independent risk factors for waitlist death. An unusual finding in that study was that shorter stature also predicted worse outcomes, likely because smaller patients are harder to match with available organs.11PubMed Central. Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis These same clinical complications were also associated with a lower chance of being transplanted, creating a double disadvantage: the patients least likely to survive the wait are often the hardest to transplant.
Disparities by Race, Sex, and Socioeconomic Status
The transplant system does not treat everyone equally, even setting geography aside. Research has consistently found that Black and Hispanic patients have lower rates of referral for liver transplant evaluation, tend to present with more advanced liver disease and more advanced liver cancer at diagnosis, and are less likely to undergo living-donor transplant.12PubMed. Racial, Gender, and Socioeconomic Disparities in Liver Transplantation Medicaid insurance has been linked to worse waitlist outcomes compared with private insurance.
A more recent analysis examining disparities within and across transplant referral regions found that Black patients had lower rates of being listed relative to liver-disease deaths than white patients in 80% of transplant regions. For Hispanic patients, the picture was more mixed, with listing rates comparable to or higher than white patients in just over half of regions.13PubMed Central. Racial and ethnic disparities in liver transplant access vary within and across transplant referral regions These disparities arise before patients even reach the waiting list, at the level of referral and evaluation, which means the MELD score system cannot fix them on its own.
Expanding the Donor Pool
One reason the chances of getting a transplant have improved in recent years is that the pool of usable organs has grown. Living-donor liver transplant, where a healthy person donates a portion of their liver, has expanded steadily in the United States. It offers a way to shorten waiting times and reduce the risk of dying on the list, and the transplant community is working to broaden both donor and recipient eligibility criteria.14PubMed. Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange, and non-directed donor graft allocation Initiatives like liver paired exchange, where incompatible donor-recipient pairs swap with other pairs, and nondirected donation, where someone donates without a specific recipient in mind, are being developed to push this further.
On the deceased-donor side, organs that once would have been discarded are now being used thanks to improved preservation technology. Machine perfusion, which pumps oxygenated fluid through a donor liver outside the body, has allowed transplant teams to evaluate and rehabilitate organs from donors who are older, have fatty livers, or have other characteristics that previously made them too risky to use.15PubMed Central. Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain? Another strategy involves accepting livers from donors who test positive for hepatitis C. With highly effective antiviral treatments now available, these organs can be transplanted safely into recipients who then receive a short course of medication. For patients with liver cancer listed under exception points, consenting to receive an HCV-positive organ was associated with a roughly 46% higher likelihood of being transplanted and a lower risk of dying on the waiting list.16PubMed. HCV NAT+ consent improves liver transplant and waitlist mortality in patients listed for HCC MELD exceptions
Bridging Therapies for Cancer Patients on the List
If you are listed for transplant because of liver cancer, your transplant team will likely recommend some form of treatment to control the tumor while you wait. These “bridging therapies” can include procedures that destroy tumor cells with heat, cold, or radiation, or that cut off the tumor’s blood supply. The goal is to keep the cancer from growing beyond the size and number thresholds that make you eligible for transplant. A meta-analysis found that patients who received bridging therapy waited longer before transplant on average but had better survival after transplant at one, three, and five years compared with patients who received no treatment while waiting.17PubMed. Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis on intention-to-treat outcomes In smaller studies, none of the patients who received bridging therapy dropped out of the waitlist due to tumor progression.18PubMed Central. Outcomes of Bridging Therapy in Liver Transplantation for Hepatocellular Carcinoma These therapies are now standard of care at most transplant centers for cancer patients facing a significant wait.
What Survival Looks Like After Transplant
Getting the transplant is only part of the story. Post-transplant survival has improved substantially over the decades but is far from perfect. A landmark study of 4,000 consecutive patients at a single center reported survival rates of 79% at one year, 67% at five years, and 57% at ten years.19PubMed Central. Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center A more recent nationwide database study found a 12-year survival rate of 68%, suggesting improvements in surgical technique, immunosuppression, and post-operative care have pushed the curve upward. The leading cause of death after transplant remained liver-related, accounting for more than 65% of deaths.20PubMed. Causes of death and associated factors with death after liver transplantation: a nationwide database study
For patients who need a second transplant because the first graft fails, the outlook is dimmer. One-year survival after re-transplantation has been reported at around 54–61%, and five-year survival at roughly 42–54%, both well below first-transplant figures.21PubMed Central. Decision for Retransplantation of the Liver: An Experience- and Cost-Based Analysis When the first graft fails late, rather than in the immediate post-operative period, five-year survival after re-transplant is around 42%.22PubMed. Retransplantation for late liver graft failure: predictors of mortality Re-transplantation decisions are made carefully and weigh the patient’s age, kidney function, and urgency against the reality that a second organ is being used for one person when it could potentially go to someone receiving a first transplant.
Pediatric Candidates Face Different Challenges
Children on the liver transplant waiting list deal with a distinct set of problems. Size matching is harder because donor livers need to fit a child’s smaller body, and there are far fewer pediatric-sized donors. An analysis of offers to pediatric candidates found that of more than 11,000 donor livers offered to children, only about 12% were actually transplanted into children. About half of those were initially refused for one child before being accepted for another. Among children who died or were removed from the list, 45% never received a single organ offer, while 55% received at least one offer of a liver that was eventually transplanted into a different child.23PubMed Central. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List Meanwhile, about 6% of adult transplant recipients received a liver from a donor under 18, typically a teenager, most of which were allocated locally or regionally. The competition between adult and pediatric recipients for the same pool of smaller donors is an ongoing ethical and logistical challenge.
When You Need More Than Just a Liver
Some patients with end-stage liver disease also have severe kidney problems, which raises the question of whether to transplant both organs at once. Simultaneous liver-kidney transplant (SLK) has formal eligibility criteria in the U.S., typically requiring evidence of advanced chronic kidney disease or sustained dialysis. After the 2017 policy establishing these criteria, about 94% of SLK registrations met the requirements, and transplant volume held roughly steady at around 700–740 per year.24PubMed. Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy
The survival benefit of SLK over liver-alone transplant is real but not universal. An analysis of more than 5,400 recipients found that SLK was associated with lower one-year mortality overall, but when the data were broken down by the reason for kidney disease, the sustained survival benefit was only clear in patients with end-stage kidney disease. Patients who met SLK criteria for other reasons, like acute kidney injury or moderate chronic kidney disease, did not show the same lasting advantage.25PubMed. One size does not fit all: Differential benefits of simultaneous liver-kidney transplantation by eligibility criteria For patients whose kidneys might recover after a liver transplant, the current system includes a “safety net” that gives priority access to a kidney transplant within one year if the kidneys do not bounce back. That safety-net pathway saw a fourfold increase in transplant rates and a decline in waitlist mortality after it was implemented.24PubMed. Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy